MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

Naturalistic study of depression and Parkinson´s Disease in a third level of attention in Mexico City

R. Janssen Aguilar, A. Ruiz Chow, M. Rodriguez Violante, P. Rojas Castañeda, A. Cervantes Arriaga, E. Ruiz Sanchez, Y. Alcantara Flores, A. Marquez Duarte (Mexico City, Mexico)
Navigating therapeutic landscapes with Parkinson’s disease in a scarce biomedical healthcare setting: the case of Kenya

N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Hooker, J. Kwasa, R. Walker (Newcastle upon Tyne, United Kingdom)
Network-Based Healthcare at Kaiser Permanente

P. Hickey, T. Sachs, S. Cedrone, C. Distasio, N. Adachi, H. Bremner, G. Etter, M. Munneke, L. Rompen, B. Bloem (Los Angeles, CA, USA)
Neural activity in the subthalamic nucleus in association with reward/loss processing in patients with Parkinson’s disease

CC. Zhang, J. Li, L. Manssuer, Q. Ding, L.B Wang, B.M Sun, D.Y Li, V. Voon (Shanghai, China)
Neural bases of dystonia penetrance and manifestation

S. Khosravani, G. Chen, K. Simonyan (Boston, MA, USA)
Neural Correlates of Semantic Fluency Deficits in Parkinson’s Disease with Mild Cognitive Impairment

J. Yang, G. Byrne, J. O'Sullivan, K. McMahon, D. Copland, N. Dissanayaka (Herston, Australia)
Neurodevelopmental disorder and parkinsonism in a patient with WDR45 variant: a long-term outcome

F. Manti, F. Nardecchia, S. Galosi, C. Panteghini, B. Garavaglia, V. Leuzzi (Rome, Italy)
Neuroimaging Extra-Striatal D2 Receptors in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder

M. Valli, SS. Cho, M. Masellis, R. Chen, Y. Koshimori, M. Diez-Cirarda, A. Mihaescu, A. Strafella (Toronto, ON, Canada)
Neuroimaging of anxiety in Parkinson’s disease: a systematic review

G. Carey, M. Görmezoğlu, K. Dujardin, A. Leentjens (Maastricht, Netherlands)
Neuroimaging Software Assisted Deep Brain Stimulation (DBS) Programming in Patients with Parkinson’s Disease (PD)

H.F Chan, Y.F Cheung, T.L Poon, M.H Yuen, F.C Cheung, W.L Poon, W.C Fong (Hong Kong, Hong Kong)
Neuroinflammation and Myelin changes in MSA-P evaluated using Advanced Diffusion MRI and Myelin Sensitive Imaging Techniques

T. Ogawa, T. Hatano, K. Kamagata, C. Andica, H. Takeshige-Amano, W. Uchida, D. Kamiyama, Y. Shimo, G. Oyama, A. Umemura, H. Iwamuro, M. Ito, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)
Neuronal Inclusion Formation and Axonal Degeneration in Mutant TFG Transgenic Mice

T. Kawarai, A. Orlacchio, R. Kaji (Tokushima, Japan)
Neuropathological Changes Following PPN Region DBS

V. Vedam-Mai, A. Elkouzi, S. Prokop, A. Yachnis, K. Foote, L. Almeida, A. Ramirez-Zamora, M. Okun (Gainesville, FL, USA)
Neuroprotective and neuromodulatory properties of Olea purpurea leaf extract in MPTP intoxicated Parkinsonian rat model

A. Singh, T. Yadav, A. Pandey (Allahabad, India)
Neuroprotective effects of allicin microemulsion against intrastriatal rotenone and manganese induced Parkinsonism in rats

S. Singh (Moga, India)
Neuroprotective propensity of marmelosin against 6-OHDA-induced cognitive impairment and apoptosis via upregulation of PI3K/Akt pathway

E. Yadav (Allahabad, India)
Neuropsychiatric non-motor manifestations in patients with focal dystonia

H.W Shin (Seoul, Republic of Korea)
Neurosonography of substantia nigra in patients with isolated essential tremor and in association with Parkinson’s disease of the family nature

S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)
New compound increasing glucocerebrosidase activity on primary cell cultures obtained from patients with GBA-associated Parkinson’s disease

M. Nikolaev, A. Kopytova, K. Senkevich, G. Baydakova, I. Miliukhina, E. Zakharova, G. Rychkov, A. Cheblokov, F. Ibatullin, S. Pchelina, A. Emelyanov (Gatchina, Russian Federation)
New onset Tongue Tremor with Tacrolimus following Heart Transplantation

E. Gray, K. Frei (Loma Linda, CA, USA)
New pathogenic mutation in the Niemann-Pick C (NPC) Type 1 gene: Confirmation by diagnostic workup of NPC in a 41-year-old woman with idiopathic late onset cerebellar ataxia (ILOCA)

G. Crotty, J.Y Chen, D. Brockman, J. Schmahmann (Boston, MA, USA)
New tool to localize seizure onset zone from sEEG signal-connectivity epileptogenicity index

A. Balatskaya (Moscow, Russian Federation)
Niemann-Pick Type C Presenting as Progressive Supranuclear Palsy

J. Kim, G. Lee (Busan, Republic of Korea)
NILO-PD: A Phase 2A Study of Nilotinib in Patients with Moderately Advanced Parkinson’s Disease: Exploratory Efficacy Outcomes

T. Simuni, C. Coffey, E. Klingner, C. Caspell-Garcia, D.E Lafontant, K. Merchant, B. Fiske, H. Matthews, R. Wyse, P. Brundin, D. Simon, M. Schwarzschild, D. Weiner, J. Adams, L. Trusso, L. Baker, M. Kostrzebski, C. Venuto, G. Rafaloff, T. Ward (Chicago, IL, USA)
Nivolumab-induced choreoathetosis in a woman with lung cancer – A case report with review of the literature

J. Johansson Lindgren, M. Esbjörnsson, E. Tüzün, H. Griph, D. Van Westen, G. Sahin (Hässleholm, Sweden)
No frank biochemical evidence of proteinopathy in the cerebellar cortex of patients with essential tremor

A. Rajput, A. Rajput, C. Tremblay, F. Calon, K. Melançon, E. Aubry-Lafontaine, E. Brochu, S. Paris-Robidas (Quebec, QC, Canada)
No pathogenic mutations in HPCA in Chinese dystonia patients

J. Ma, Y.M Liu (Jinan, China)
Nomencladventure: Palatal myoclonus and palatal tremor

D. Riley (Cleveland, OH, USA)
Non-Ketotic Hyperglycemic Hemichorea as an initial manifestation of type 2 diabetes

P. Karau, J. Hooker, G. Mbijiwe (Meru, Kenya)
Non-mercaptalbumin as a potential biomarker of oxidative stress in Parkinson’s and PARK2 disease

S. Ueno, T. Hatano, A. Okuzumi, S. Saiki, Y. Oji, A. Mori, T. Koinuma, M. Fujimaki, H. Takeshige-Amano, A. Kondo, N. Yoshikawa, T. Nojiri, M. Kurano, K. Yasukawa, Y. Yatomi, H. Ikeda, N. Hattori (Tokyo, Japan)
Non-Motor Fluctuations in Parkinson’s Disease (PD): Development and Validation of the Non-Motor Fluctuation Assessment Instrument (NoMoFA)

G. Kleiner, H. Fernandez, K. Chou, A. Fasano, K. Duque, D. Hengartner, A. Law, A. Margolius, Y. Poon, M. Saenz-Farret, P. Saleh, J. Vizcarra, G. Stebbins, A. Espay (Toronto, ON, Canada)
Non-motor network decoupling accompanies conversion to freezing of gait in Parkinson’s disease

N. D'Cruz, S. Chalavi, M. Gilat, A. Nieuwboer (Leuven, Belgium)
Non-motor Symptoms after Treatment with Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease: Analysis of the COSMOS Observational Study

A. Johansson, V. Tomantschger, N. Kovács, A. Dulamea, O. Sánchez-Soliño, L. Bergmann, J. Carlos Parra, A. Fasano (Stockholm, Sweden)
Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study

A. Fasano, L. Bergmann, V. SC Fung, K. Onuk, K. Seppi, Z. Pirtosek (Toronto, ON, Canada)
Non-Motor Symptoms In Chinese Patients With Isolated Generalized Dystonia: A Case-Control Study

S.L Li, X.H Wan, L. Wang, YY. Mai, L. Qiao, DD. Zhang (Beijing, China)
Non-motor symptoms in Parkinson’s disease and the model of Braak

H. You, F.X Lejeune, F. Danjou, S. Bekadar, J.C Corvol (Paris, France)
Non-motor symptoms-predictors of Parkinson’s disease in patients with a hereditary form of essential tremor

Z. Zalyalova, S. Munasipova (Kazan, Russian Federation)
Non-pharmacological Treatment for Parkinson’s Disease Patients with Depression: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation and Cognitive-Behavioral Treatment

J.N Chen, P.K He, Y.H Zhang, YY. Gao, Y.H Qiu, Y. Li, Q.X Zhang, L.M Wang, J.H Zhao, K. Nie, L.J Wang (Guangzhou, China)
Non-Staged Bilateral GPi DBS Lead Revision Using iMRI: A Case Report

B. Hwang, D. Mampre, K. Mills, A. Butala, W. Anderson (Baltimore, MD, USA)
Noninvasive brain stimulation to treat hypokinetic dysarthria in PD: A sham stimulation-controlled trial

I. Rektorova, L. Brabenec, P. Klobusiakova, M. Kostalova (Brno, Czech Republic)
Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson’s disease – a PET and MRI multi-modal imaging study

M. Kinnerup, C. Doppler, E. Farrher, T. Fedorova, J. Schaldemose, K. Knudsen, R. Isamail, A. Hansen, K. Stær, G. Fink, J. Shah, D. Brooks, A. Nahimi, P. Borghammer, M. Sommerauer (Aarhus, Denmark)
Normative vs. patient-specific brain connectivity in Deep Brain Stimulation

Q. Wang, H. Akram, M. Muthuraman, G. Gonzalez-Escamilla, S. A. Sheth, G. Groppa, N. Vanegas-Arroyave, L. Zrinzo, N. Li, A. Kühn, A. Horn (Berlin, Germany)
Northwestern University Feinberg School of Medicine Parkinson’s disease and Movement Disorders Center Biorepository: bringing the clinic and lab together

A. Hernandez, S. Lubbe, T. Simuni, D. Bega, D. Krainc, N. Mencacci, R. Modiest, P. Opal, C. Taylor, N. Shetty, R. Malkani, J. Blackburn (Chicago, IL, USA)
Not so simple: the challenge of developing a non-motor symptoms app (NMS Assist) for people with Parkinson’s (PwP)

T. Gorst, T. Dominey, J. Whipps, S. Whipps, J. Cooke, S. Mullin, I. Maramba, E. Edwards, C. Carroll (Plymouth, United Kingdom)
Novel Dentato-Olivo-Luysian Atrophy in a Greek Family

S. Alshimemeri, K. Yoshida, N. Visanji, E. Rogaeva, R. Munhoz, E. Slow, A. Lang, G. Kovacs (Toronto, ON, Canada)
Novel GNO1 mutation in monozygotic twins responsive to DBS

B. Bulica (West Bloomfield, MI, USA)
Novel KCND3 mutation associated with paroxysmal motor exacerbations in spinocerebellar ataxia 19

M. Paucar, R. Ågren, T. Li, S. Lissmats, Å. Bergendal, I. Savitcheva, D. Nilsson, K. Sahlholm, P. Svenningsson, J. Nilsson (Stockholm, Sweden)
Novel Mutation in the Protein Kinase C Gamma Gene Causing Spinocerebellar Ataxia-14 in a Large Family

J. Lahrmann, M. Dagostine, D. Machado (Cheshire, CT, USA)
Novel Recessive Mitochondrial Mutations Causing Leigh’s Syndrome and Movement Disorders

B. Barton, C. Toro (Chicago, IL, USA)
Novel walker attachment for gait dysfunction in Parkinson’s disease: Case report

C. Gill, P. Schmitt, J. Karl, L. Verhagen Metman (Chicago, IL, USA)
Nucleus basalis of Meynert free-water distinguishes and predicts cognitive impairment and longitudinally correlates with cognitive changes in early Parkinson’s disease

T. Guttuso, Jr., D. Tosun, R. Zivadinov, O. Pasternak, D. Weintraub, N. Bergsland (Buffalo, NY, USA)
Nurse led intrajejunal levodopa pathway for a regional neurosciences centre

P. Duggan-Carter, J. Cosgrove, J. Alty (Leeds, United Kingdom)
NUS1 polymorphisms modify the risk and age at onset of Parkinson’s disease

L. Jiang, J. Mei, Y. Zhao, R. Zhang, H. Pan, Y. Yang, Q. Sun, Q. Xu, X. Yan, J. Tan, J. Li, B. Tang, J. Guo (Changsha, China)
Nutrient patterns in Parkinson’s disease: A case-control study

S. Diaconu, A. Maceasa, B. Ciopleias, R. Zosin, C. Falup-Pecurariu (Braşov, Romania)

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z